Adam Raff, M.D., Ph.D. currently serves as Vice President and Head of Translational Medicine at Montai Therapeutics. Previously, Adam has held positions at Beth Israel Deaconess Medical Center as a Dermatologist and at Harvard Medical School as an Instructor. Adam also worked at EQRx, where roles included Vice President of Immunology and Senior Medical Director. Furthermore, Adam was Director of Translational Medicine at LEO Pharma. Adam Raff's education includes training at Harvard Medical School - Massachusetts General Hospital from 2015 to 2017 and studies at Harvard University from 2013 to 2016.